Effect of CD on the antiaging drug: rapamycin
Rapamycin (also known as sirolimus) is a macrolide compound produced by the bacterium Streptomyces hygroscopicus. It is immunosuppressant used to
Category: CD derivatives
Cyclodextrins at HPLC 2019 Milan
HPLC 2019, the most important international conference in the field of high-performance liquid phase separations and related techniques, will be
CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo (TM) in Alzheimer’s Disease
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
A HPBCD solubilized novel fusion inhibitor of influenza virus was found orally active in mice
A group of researchers employed by different subsidiaries of Janssen Research & Development, Scripps Research Institute, Department of Epidemiology, as well
Special issue “Cyclodextrins: past, present and future”
A selection of presentations at the 19th International Cyclodextrin Symposium (April 27–30, 2018, Sophia University of Tokyo, Japan) was collected
4th International Summer School on Cyclodextrins
The 4th International Summer School on Cyclodextrins welcomes graduate students, Ph.D students and researchers interested in all the aspects of
CDs in capillary electrophoresis
CDs became popular chiral selectors in capillary electrophoresis due to the versatility of their derivatives. The number of papers
Antidepressant drug to treat sepsis
Sepsis is an often deadly complication of infection in which systemic inflammation damages the vasculature, leading to tissue hypoperfusion and
CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
CDs in hydrogen storage
Hydrogen as clean and renewable energy source could replace fossil fuels, but the lack of method for efficient storage inhibits